Sensing opioid withdrawal and cravings with wearable sensors
Part of Mental health clinical trials.
This study uses wearable sensors to track physical signs of opioid withdrawal and cravings over 14 days. It aims to better understand these symptoms in people currently taking or planning to start medication for opioid use disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had recent opioid dependence (prescription or not)
- Currently taking or planning to start medication for opioid use disorder (MOUD)
- Between 18 and 50 years old
- Fluent in English
- No uncontrolled medical or psychiatric condition, history of seizures, or recent suicidal thoughts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a physical device (ADTPM 1) to help manage withdrawal symptoms in people who are dependent on opioids. The goal is to see if the device can safely reduce withdrawal discomfort.
This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.
This study tests if a smartphone app can help people taking medications for opioid use disorder and who also have alcohol use disorder. You will use the app for 6 months and provide feedback through surveys and saliva drug tests.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.
Hear when a new Opioid Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.